slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 61,321-61,350
Pages 3,679
Rows per page 30
Component
61,321-61,350 of 110,355
06
The slide uses a checklist format to distinguish between completed actions (checked) and future actions (unchecked).Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
07
The slide uses a split layout: blue boxes for specific leverage targets and a list for cash generation sources.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
10
The table uses a hierarchical structure to group segments under Bausch + Lomb and Bausch Pharma, with a final total for Bausch Health.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
11
Includes detailed footnotes regarding non-GAAP adjustments and organic growth calculations.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
14
Includes a disclaimer box at the top right and detailed footnotes at the bottom.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
15
Includes a callout box highlighting GAAP vs non-GAAP operating cash flow figures.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
16
Includes detailed footnotes regarding debt adjustments and divestiture impacts.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
17
The slide provides a breakdown of secured and unsecured debt maturities from 2022 to 2031.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
23
The slide uses a winding path diagram to represent a business process or customer journey.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
24
Includes multiple chart types (bar, line, area) to demonstrate positive growth trajectories post-COVID-19.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
26
Includes footnotes regarding non-GAAP measures and data sources.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
28
The slide uses bar charts to show growth across six metrics.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
29
Includes geographic map visualization of top products by region and donut charts for revenue distribution.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
34
The slide illustrates a corporate restructuring where Bausch + Lomb and Solta Medical are separated from Bausch Pharma.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
36
The slide lists specific clinical trial milestones and product launch timelines for three distinct business units.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
37
The slide uses a matrix-style timeline layout to track clinical trial progress across four distinct drug programs.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
40
Bausch Health Companies | Results Presentation Deck | 86 slidesBausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
42
Includes both GAAP and non-GAAP measures; highlights organic and reported revenue growth.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
43
Includes a callout for new disclosure regarding GAAP measures.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
47
Includes specific disclosures regarding non-GAAP measures and corporate allocation exclusions.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
48
Includes both GAAP and non-GAAP measures with footnotes regarding constant currency and organic growth definitions.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
53
The table includes footnotes regarding non-GAAP measures and constant currency calculations.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
54
The table highlights key product revenue trends for FY21, 4Q21, 3Q21, 2Q21, 1Q21, FY20, and 4Q20.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
55
The table provides a detailed breakdown of revenue in millions for each product, allowing for year-over-year and quarter-over-quarter comparison.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
56
The table provides a comparative view of product revenue, highlighting Xifaxan as the primary revenue driver.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
57
The table includes 8 columns of financial data for 10 products, totaling 80 distinct data points.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
58
The table highlights FY21 and FY20 columns with a blue background for emphasis.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
59
The table tracks revenue in millions for 10 specific products across 7 time periods.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
60
Includes both GAAP and non-GAAP measures; explicitly notes exclusion of corporate G&A and R&D allocation.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit
61
Includes both GAAP and non-GAAP measures; explicitly notes exclusion of corporate G&A and R&D allocation.Bausch Health Companies | Results Presentation Deck | 86 slides · Bausch Health
Conference presentation Investor relations 1 hit